On December 7, 2021, the Council of Ministers approved a series of amendments affecting the regulations of the Fund for the recapitalization of companies affected by COVID-19.
These modifications were made in response to the observation of the existence of numerous situations of companies that, experiencing difficulties directly or indirectly attributable to the pandemic, did not qualify in accordance with the criteria established at the creation of the Fund.
The most important changes in the requirements for companies to access the fund are:
- The minimum turnover of companies eligible for this fund has been reduced to EUR 10 million from the previous EUR 15 million. The turnover range is therefore between EUR 10 million and EUR 400 million.
- Access to the Cofides Fund is open to companies with a turnover of more than EUR 400 million, which did not reach the minimum amount of aid provided for in this Fund.
- The Fund's new range of grants is between EUR 2.5 million and EUR 25 million.
- The requirement for a 20% drop in 2020 turnover compared to 2019 is eliminated.
- Justification of the deterioration of the capital structure (Net Equity/Net Financial Debt) is allowed based on the comparison of the closing of 2021 versus 2019.
- Companies considered to be in crisis at the end of 2019 are accepted as beneficiaries of the Fund, provided that at the time of applying for assistance from the Fund, they had reversed this situation.
- The maximum amount of aid from the Fund in the form of an ordinary loan will be the most favorable of: (i) twice the beneficiary's annual salary costs as of 2019 or the last year available, (ii) 25% of the total turnover for 2019. For the purposes of the latter calculation, the ICO Covid loans that the companies would have requested are also computed as ordinary debt with state aid.
These modifications apply to the Fund for the recapitalization of companies affected by COVID-19 created in March 2021, whose management was entrusted to the public-private commercial company Cofides. It is a tool oriented to medium-sized companies of any sector which, enjoying viability before COVID-19 and having it in the medium and long term, were strongly affected by the effects of the pandemic.
1 billion and is governed by the European and national Temporary Framework for State aid measures to support the economy in the context of COVID-19.
Cofides will operate with equity or hybrid instruments (such as participating loans), which must be amortized over a maximum term of 8 years, and with ordinary loans, which must be amortized over a maximum term of 6 years.
The capital instruments cannot result in an improvement of the 2019 year-end capital structure, understood as the Net Equity/Net Financial Debt ratio.
The six-month extension granted last November by the European Commission (from December 31, 2021 to June 30, 2022) provides an oxygen balloon, although perhaps insufficient (from December 31, 2021 to June 30, 2022) provides an oxygen balloon, although perhaps insufficient, so that the companies can use part of the funds necessary for their recovery and continuity.
A delayed effect, which will occur throughout 2022, is the end of the maximum grace period of the EUR 140 billion of bank loans guaranteed by ICO. The debt service on these loans will most likely exceed the cash generation capacity of many companies, especially those that requested them in 2020, to cover the heavy losses they were suffering.
Levante EMV
PKF Attest advises and assists companies to access the Cofides recapitalization fund
Access here >>
Valencia Plaza
PKF Attest advises and assists companies to access the Cofides recapitalization fund
Access here >>
The Economist
PKF Attest assists companies in accessing the fonrec
Click here >>
We offer advice on Financing, both for the Search for Capital and for the Obtaining of Debt, depending on the specific needs of your company.
